Global Intravenous Therapy (IV) Market, By Material Type (Polypropylene, Polyvinyl Chloride, Polyethylene, Copolyester Ether, EVA), Capacity (0-250 ml, 250-500ml, 500-1000 ml, Above 1000 ml), Chamber Type (Single Chamber, Multi Chamber), Application (Parenteral Nutrition, Intravenous Therapies), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Global Intravenous Therapy (IV) Market
The intravenous therapy (IV) market will grow at a CAGR of 6.25% for the forecast period of 2021 to 2028. Rise in the easy availability and affordable pricing of Intravenous therapy (IV) is an essential factor driving the intravenous therapy (IV) market.
Intravenous therapy are used to deliver liquid substances directly into veins. As the intravenous therapy meet various medical requirements, such as preserving capacity, sterilization, transportation, and handling needs, the intravenous therapy (IV) market is anticipated to gain more popularity in the upcoming years.
Rise in the use of injections for delivering fluids and medicines, among other liquid nutritional substances directly into the bodies of patients with swallowing issues is the major factor escalating the market growth, also rise in the growth in the penetration of the clinical facilities, particularly in emerging economies, rise in the government initiatives, rise in the prevalence of malnutrition, and increasing incidence of cancer all over the globe are the major factors among others propelling the growth of intravenous therapy (IV) market . Moreover, rise in the acceptance of innovative healthcare technologies, rise in the disease prevalence, increasing investments for improving healthcare infrastructure and rise in the research and development activities in the market will further create new opportunities for the intravenous therapy (IV) market in the in the forecast period of 2021- 2028.
However, rise in the risk of leaching of chemicals from the plastic Intravenous therapy (IV) is the major factors among others restraining the market growth, and will further challenge the growth of Intravenous therapy (IV) market.
This intravenous therapy (IV) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on intravenous therapy (IV) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Intravenous Therapy (IV) Market Scope and Market Size
The intravenous therapy (IV) market is segmented on the basis of material type, capacity, chamber type and application. The growth amongst the different segments helps you in attaining the knowledge related to the different growth factors expected to be prevalent throughout the market and formulate different strategies to help identify core application areas and the difference in your target markets.
- On the basis of material type, the intravenous therapy (IV) market is segmented into polypropylene, polyvinyl chloride, polyethylene, copolyester ether and EVA.
- Based on capacity, the intravenous therapy (IV) market is segmented into 0-250 ml, 250-500ml, and 500-1000 ml and above 1000 ml.
- Based on chamber type, the intravenous therapy (IV) market is segmented into single chamber and multi chamber.
- The intravenous therapy (IV) market is also segmented on the basis of application into parenteral nutrition and intravenous therapies.
Intravenous Therapy (IV) Market Country Level Analysis
The intravenous therapy (IV) market is analysed and market size, volume information is provided by material type, capacity, chamber type and application as referenced above.
The countries covered in the Intravenous therapy (IV) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates intravenous therapy (IV) market due to rise in the acceptance of innovative healthcare technologies, rise in the presence of key players, high prevalence of diseases like cancer, vomiting, diarrhea, rise in the established healthcare infrastructure and rise in the number of research partnerships in this region.
The country section of the intravenous therapy (IV) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Intravenous Therapy (IV) Market Share Analysis
The intravenous therapy (IV) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to intravenous therapy (IV) market.
The major players covered in the intravenous therapy (IV) market report are B. Braun Melsungen AG, Baxter, Pfizer Inc, Technoflex SA, Fresenius SE & Co. KGaA, KRATON CORPORATION, The Metrix Company, Medicopack A/S, Macopharma, Haemotronic, Otsuka Pharmaceutical India Pvt. Ltd, alfa Laboratory, Qosina, ICU Medical, JW Life Science and Angiplast among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-